Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice

被引:33
|
作者
Veinbergs, I
Mante, M
Jung, MW
Van Uden, E
Masliah, E [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA
[3] Ajou Univ, Inst Med Sci, Sch Med, Dept Physiol,Neurosci Lab, Suwon 441749, South Korea
关键词
Alzheimer's disease; apolipoprotein E; calcium homeostasis; electrophysiology; Morris water maze; synaptotagmin;
D O I
10.1016/S0278-5846(99)00013-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1. Aged apoE-deficient mice and age-matched controls were tested for cognitive alterations in the Morris water maze. 2. Water maze results were correlated with in vivo electrophysiology and expression of the synaptic protein synaptotagmin (p65). 3. Compared to age-matched controls, apolipoprotein E-deficient mice displayed significant performance impairment accompanied by in vivo electrophysiological alterations in the dentate gyrus. 4. Apolipoprotein B-deficient mice also showed a significant increase in the synaptic protein, synaptotagmin, a synaptic calcium sensor involved in neurotransmitter release. 5. Cognitive impairments in these animals may be associated with decreased synaptic excitability in hippocampal neurons and the regulatory role of apolipoprotein E in synaptic function might be mediated by modulation of the expression of calcium sensor proteins.
引用
收藏
页码:519 / 531
页数:13
相关论文
共 50 条
  • [1] Distinct alterations in phospholipid metabolism in brains of apolipoprotein E-deficient mice
    Lomnitski, L
    Oron, L
    Sklan, D
    Michaelson, DM
    JOURNAL OF NEUROSCIENCE RESEARCH, 1999, 58 (04) : 586 - 592
  • [2] Development of Apolipoprotein E-Deficient Mice
    Maeda, Nobuyo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (09) : 1957 - 1962
  • [3] Diet and Atherosclerosis in Apolipoprotein E-Deficient Mice
    Imaizumi, Katsumi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2011, 75 (06) : 1023 - 1035
  • [4] Renal injury in apolipoprotein E-deficient mice
    Wen, M
    Segerer, S
    Dantas, M
    Brown, PA
    Hudkins, KL
    Goodpaster, T
    Kirk, E
    LeBoeuf, RC
    Alpers, CE
    LABORATORY INVESTIGATION, 2002, 82 (08) : 999 - 1006
  • [5] Hyperphosphorylation of tau in apolipoprotein E-deficient mice
    Genis, I
    Michaelson, DM
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 251 - 256
  • [6] Therapy of Atherosclerosis in Apolipoprotein E-Deficient Mice
    Wang, Min
    Yang, Hua
    Tan, Mengqun
    MOLECULAR THERAPY, 2014, 22 : S231 - S231
  • [7] PHOSPHORYLATION OF TAU IN APOLIPOPROTEIN E-DEFICIENT MICE
    GENIS, I
    GORDON, I
    SEHAYEK, E
    MICHAELSON, DM
    NEUROSCIENCE LETTERS, 1995, 199 (01) : 5 - 8
  • [8] Ocular cytopathy in apolipoprotein E-deficient mice
    Ong, JM
    Rosenberg, SE
    Zorapapel, NC
    Rajeev, B
    Nesburn, AB
    Kenney, MC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S920 - S920
  • [9] Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice
    d'Uscio, LV
    Baker, TA
    Mantilla, CB
    Smith, L
    Weiler, D
    Sieck, GC
    Katusic, ZS
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (06) : 1017 - 1022
  • [10] Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice
    Okamoto, Y
    Kihara, S
    Ouchi, N
    Nishida, M
    Arita, Y
    Kumada, M
    Ohashi, K
    Sakai, N
    Shimomura, I
    Kobayashi, H
    Terasaka, N
    Inaba, T
    Funahashi, T
    Matsuzawa, Y
    CIRCULATION, 2002, 106 (22) : 2767 - 2770